AstraZeneca has dragged Dr Reddy's Laboratories to the court to protect its blood clot inhibitor drug Brilinta from generic competition
from Latest News https://ift.tt/2Kdnw7F
Tuesday, 31 July 2018
AstraZeneca-DRL patent case: Fate of Rs 2.35 bn drug to be decided today
Subscribe via email
About Unknown
SoraTemplates is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of SoraTemplates is to provide the best quality blogger templates.
Newer Article
Avenue Supermarts hits new high on strong Q1 results
Older Article
Monetary Policy preview: Will the RBI hike interest rates tomorrow?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment